GameStop GME is projected to report its Q4 earnings at $1.92 per share on revenue of $3.79 billion.
Accenture plc ACN is expected to report its Q2 earnings at $1.04 per share on revenue of $7.21 billion.
Conns CONN is estimated to report its Q4 earnings at $0.78 per share on revenue of $362.86 million.
Red Hat RHT is expected to post its Q4 earnings at $0.37 per share on revenue of $398.92 million.
Commercial Metals Company CMC is projected to report its Q2 earnings at $0.10 per share on revenue of $1.70 billion.
Lululemon Athletica LULU is expected to report its Q4 earnings at $0.72 per share on revenue of $515.11 million.
Worthington Industries WOR is projected to report its Q3 earnings at $0.58 per share on revenue of $760.73 million.
Restoration Hardware Holdings RH is expected to post its Q4 earnings at $0.83 per share on revenue of $493.09 million.
Heska HSKA is estimated to report its Q4 earnings at $0.04 per share on revenue of $18.84 million.
Winnebago Industries WGO is expected to report its Q2 earnings at $0.30 per share on revenue of $199.57 million.
Leidos Holdings LDOS is projected to report its Q4 earnings at $0.45 per share on revenue of $1.27 billion.
Signet Jewelers SIG is estimated to report its Q4 earnings at $2.15 per share on revenue of $1.55 billion.
Progress Software PRGS is projected to post its Q1 earnings at $0.28 per share on revenue of $74.75 million.
Inogen INGN is expected to post its Q4 earnings at $0.02 per share on revenue of $18.71 million.
Oxford Industries OXM is estimated to post its Q4 earnings at $0.86 per share on revenue of $250.13 million.
RE/MAX Holdings RMAX is expected to post its Q4 earnings at $0.27 per share.
Dover Saddlery DOVR is projected to post its Q4 earnings.
Fred's FRED is expected to report its Q4 earnings at $0.15 per share on revenue of $507.09 million.
SuperCom SPCB is projected to report its Q4 earnings.
SFX Entertainment SFXE is estimated to report its Q4 earnings at $0.06 per share on revenue of $112.85 million.
Seanergy Maritime Holdings SHIP is projected to report its Q4 earnings.
Cardiome Pharma CRME is estimated to post a Q4 loss at $0.22 per share on revenue of $3.17 million.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: EarningsNewsPre-Market OutlookMarketsApparel, Accessories & Luxury GoodsConsumer DiscretionaryEarnings schedule
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in